• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潜在益生菌罗伊氏乳杆菌的细胞表面和细胞外蛋白作为有效调节剂,调节肠道上皮屏障功能。

Cell surface and extracellular proteins of potentially probiotic Lactobacillus reuteri as an effective mediator to regulate intestinal epithelial barrier function.

机构信息

Dairy Microbiology Department, College of Dairy Science and Technology, Lala Lajpat Rai University of Veterinary and Animal Science, Hisar, 125004, India.

Dairy Microbiology Division, National Dairy Research Institute, Karnal, 132001, India.

出版信息

Arch Microbiol. 2021 Aug;203(6):3219-3228. doi: 10.1007/s00203-021-02318-2. Epub 2021 Apr 8.

DOI:10.1007/s00203-021-02318-2
PMID:33830286
Abstract

The present study aimed to evaluate the potential of cell surface and extracellular proteins in regulation of intestinal epithelial barrier (IEB) function. Eight potentially probiotic L. reuteri strains were evaluated for presence of mapA gene and its expression on co-culturing with the Caco-2 cells. The ability of untreated (Viable), heat-inactivated, 5 M LiCL treated L. reuteri strains as well as their cell-free supernatant (CFS) to modulate expression of IEB function genes (hBD-2, hBD-3, claudin-1 and occludin) was also evaluated. Caco-2 cells were treated with cell surface and extracellular protein extracts and investigated for change in expression of targeted IEB function genes. The results showed that mapA gene is present in all the tested L. reuteri strains and expression of mapA and its receptors (anxA13 and palm) increase significantly on co-culturing of L. reuteri and Caco-2 cells. Also, up-regulated expression of IEB function genes was observed on co-culturing of L. reuteri (viable, heat-inactivated and CFS) and their protein extracts with Caco-2 cells in contrast to down-regulation observed with the pathogenic strain of Salmonella typhi. Therefore, this study concludes that the cell surface and extracellular protein from L. reuteri act as an effective mediator molecules to regulate IEB function.

摘要

本研究旨在评估细胞表面和细胞外蛋白在调节肠道上皮屏障 (IEB) 功能中的潜力。评估了 8 株潜在益生菌乳杆菌,以确定其 mapA 基因的存在及其与 Caco-2 细胞共培养时的表达情况。还评估了未经处理(活菌)、热灭活、5 M LiCL 处理的乳杆菌菌株以及它们的无细胞上清液 (CFS) 调节 IEB 功能基因(hBD-2、hBD-3、claudin-1 和 occludin)表达的能力。用细胞表面和细胞外蛋白提取物处理 Caco-2 细胞,并研究其对靶向 IEB 功能基因表达的变化。结果表明,mapA 基因存在于所有测试的乳杆菌菌株中,mapA 及其受体(anxA13 和 palm)的表达在乳杆菌与 Caco-2 细胞共培养时显著增加。此外,与致病性伤寒沙门氏菌相比,观察到乳杆菌(活菌、热灭活和 CFS)及其与 Caco-2 细胞共培养的蛋白提取物上调 IEB 功能基因的表达,而下调 IEB 功能基因的表达。因此,本研究得出结论,乳杆菌的细胞表面和细胞外蛋白作为有效的介导分子来调节 IEB 功能。

相似文献

1
Cell surface and extracellular proteins of potentially probiotic Lactobacillus reuteri as an effective mediator to regulate intestinal epithelial barrier function.潜在益生菌罗伊氏乳杆菌的细胞表面和细胞外蛋白作为有效调节剂,调节肠道上皮屏障功能。
Arch Microbiol. 2021 Aug;203(6):3219-3228. doi: 10.1007/s00203-021-02318-2. Epub 2021 Apr 8.
2
A mucus adhesion promoting protein, MapA, mediates the adhesion of Lactobacillus reuteri to Caco-2 human intestinal epithelial cells.一种黏液黏附促进蛋白MapA介导罗伊氏乳杆菌与Caco-2人肠上皮细胞的黏附。
Biosci Biotechnol Biochem. 2006 Jul;70(7):1622-8. doi: 10.1271/bbb.50688.
3
Selection of Fermentation Supernatant from Probiotic Strains Exhibiting Intestinal Epithelial Barrier Protective Ability and Evaluation of Their Effects on Colitis Mouse and Weaned Piglet Models.具有肠道上皮屏障保护能力的益生菌菌株发酵上清液的筛选及其对结肠炎小鼠和断奶仔猪模型影响的评价。
Nutrients. 2024 Apr 12;16(8):1138. doi: 10.3390/nu16081138.
4
Receptor-like Molecules on Human Intestinal Epithelial Cells Interact with an Adhesion Factor from Lactobacillus reuteri.人肠道上皮细胞上的受体样分子与来自罗伊氏乳杆菌的黏附因子相互作用。
Biosci Microbiota Food Health. 2012;31(4):93-102. doi: 10.12938/bmfh.31.93. Epub 2012 Oct 25.
5
Antagonistic Activity of Strains on the Adhesion Characteristics of Selected Pathogens.菌株对所选病原体黏附特性的拮抗活性。
Front Microbiol. 2017 Mar 21;8:486. doi: 10.3389/fmicb.2017.00486. eCollection 2017.
6
In Vitro Evaluation of Swine-Derived Lactobacillus reuteri: Probiotic Properties and Effects on Intestinal Porcine Epithelial Cells Challenged with Enterotoxigenic Escherichia coli K88.猪源罗伊氏乳杆菌的体外评价:益生菌特性及其对产肠毒素大肠杆菌K88攻击的猪肠道上皮细胞的影响
J Microbiol Biotechnol. 2016 Jun 28;26(6):1018-25. doi: 10.4014/jmb.1510.10089.
7
Antagonistic trait of Lactobacillus reuteri S5 against Salmonella enteritidis and assessment of its potential probiotic characteristics.鼠李糖乳杆菌 S5 拮抗肠炎沙门氏菌的特性及其潜在益生菌特性评估。
Microb Pathog. 2019 Dec;137:103773. doi: 10.1016/j.micpath.2019.103773. Epub 2019 Oct 8.
8
Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.人源益生菌罗伊氏乳杆菌菌株可不同程度地减轻肠道炎症。
Am J Physiol Gastrointest Liver Physiol. 2010 Nov;299(5):G1087-96. doi: 10.1152/ajpgi.00124.2010. Epub 2010 Aug 26.
9
Lactobacillus reuteri glyceraldehyde-3-phosphate dehydrogenase functions in adhesion to intestinal epithelial cells.罗伊氏乳杆菌甘油醛-3-磷酸脱氢酶在黏附肠上皮细胞中发挥作用。
Can J Microbiol. 2015 May;61(5):373-80. doi: 10.1139/cjm-2014-0734. Epub 2015 Mar 23.
10
Biodetoxification of fungal mycotoxins zearalenone by engineered probiotic bacterium Lactobacillus reuteri with surface-displayed lactonohydrolase.工程化益生菌乳杆菌(Lactobacillus reuteri)通过表面展示内酯水解酶对真菌毒素玉米赤霉烯酮的生物解毒作用。
Appl Microbiol Biotechnol. 2019 Nov;103(21-22):8813-8824. doi: 10.1007/s00253-019-10153-1. Epub 2019 Oct 18.

引用本文的文献

1
Prophylactic and therapeutic effects of Limosilactobacillus reuteri E on 5-fluorouracil-induced intestinal mucositis in Caco-2 cells.罗伊氏乳杆菌E对5-氟尿嘧啶诱导的Caco-2细胞肠道黏膜炎的预防和治疗作用
Folia Microbiol (Praha). 2025 Aug 28. doi: 10.1007/s12223-025-01310-3.
2
Microbiome-based therapeutics towards healthier aging and longevity.基于微生物群的疗法促进更健康的衰老和长寿。
Genome Med. 2025 Jul 1;17(1):75. doi: 10.1186/s13073-025-01493-x.
3
Real-world of Limosilactobacillus reuteri in mitigation of acute experimental colitis.

本文引用的文献

1
Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis.感染威胁、肠道屏障及其特洛伊木马:肠道菌群失调
Front Microbiol. 2019 Aug 7;10:1676. doi: 10.3389/fmicb.2019.01676. eCollection 2019.
2
The intestinal barrier: a fundamental role in health and disease.肠道屏障:在健康与疾病中发挥的重要作用。
Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):821-834. doi: 10.1080/17474124.2017.1343143. Epub 2017 Jun 26.
3
Leaky Gut As a Danger Signal for Autoimmune Diseases.肠漏作为自身免疫性疾病的危险信号。
罗伊氏乳杆菌在减轻急性实验性结肠炎中的实际应用
J Nanobiotechnology. 2025 Jan 31;23(1):65. doi: 10.1186/s12951-025-03158-8.
4
Comparative Genomics of YLR001 Reveals Genetic Diversity and Probiotic Properties.YLR001的比较基因组学揭示了遗传多样性和益生菌特性。
Microorganisms. 2024 Aug 10;12(8):1636. doi: 10.3390/microorganisms12081636.
5
Direct and indirect effects of pathogenic bacteria on the integrity of intestinal barrier.病原菌对肠道屏障完整性的直接和间接影响。
Therap Adv Gastroenterol. 2023 May 30;16:17562848231176427. doi: 10.1177/17562848231176427. eCollection 2023.
6
The role of potential probiotic strains in various intestinal diseases: New roles for an old player.潜在益生菌菌株在各种肠道疾病中的作用:老角色的新作用。
Front Microbiol. 2023 Feb 2;14:1095555. doi: 10.3389/fmicb.2023.1095555. eCollection 2023.
7
The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies.黏附因子在益生菌对成人和儿童胃肠道功能中的潜在作用:实验和人体研究的叙述性综述。
Gut Microbes. 2022 Jan-Dec;14(1):2149214. doi: 10.1080/19490976.2022.2149214.
8
Decreased mucosal adhesion of species in patients with inflammatory bowel disease.炎症性肠病患者体内物种的黏膜黏附性降低。
Caspian J Intern Med. 2022 Fall;13(4):713-720. doi: 10.22088/cjim.13.4.71.
Front Immunol. 2017 May 23;8:598. doi: 10.3389/fimmu.2017.00598. eCollection 2017.
4
Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens.益生菌工程:致力于开发具有增强功能特性的强大益生菌菌株并用于肠道病原体的靶向控制。
Gut Pathog. 2017 May 8;9:28. doi: 10.1186/s13099-017-0178-9. eCollection 2017.
5
Antagonistic Activity of Strains on the Adhesion Characteristics of Selected Pathogens.菌株对所选病原体黏附特性的拮抗活性。
Front Microbiol. 2017 Mar 21;8:486. doi: 10.3389/fmicb.2017.00486. eCollection 2017.
6
Hypocholesterolemic effects of Lactobacillus reuteri LR6 in rats fed on high-cholesterol diet.罗伊氏乳杆菌LR6对高胆固醇饮食喂养大鼠的降胆固醇作用。
Int J Food Sci Nutr. 2015 Feb;66(1):71-5. doi: 10.3109/09637486.2014.953450. Epub 2014 Sep 29.
7
Intestinal barrier in inflammatory bowel disease.炎症性肠病中的肠道屏障
World J Gastroenterol. 2014 Feb 7;20(5):1165-79. doi: 10.3748/wjg.v20.i5.1165.
8
Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines.鼠李糖乳杆菌 GG 对麦胶蛋白诱导的上皮屏障破坏的修复:细胞多胺的作用。
BMC Microbiol. 2014 Jan 31;14:19. doi: 10.1186/1471-2180-14-19.
9
Adhesive ability means inhibition activities for lactobacillus against pathogens and S-layer protein plays an important role in adhesion.黏附能力是指乳酸菌对病原体的抑制活性,而 S-层蛋白在黏附中起着重要作用。
Anaerobe. 2013 Aug;22:97-103. doi: 10.1016/j.anaerobe.2013.06.005. Epub 2013 Jun 21.
10
Shotgun phage display of Lactobacillus casei BL23 against collagen and fibronectin.利用乳杆菌 BL23 对胶原蛋白和纤维连接蛋白进行基因文库的噬菌体展示。
J Microbiol Biotechnol. 2011 Feb;21(2):197-203. doi: 10.4014/jmb.1009.09011.